RS Oncology works collaboratively with organizations and foundations around the globe, bridging connections between universities and patients.
Azierta and RSO logo
RS Oncology and Azierta Foundation have established a unique corporate/NGO partnership for the development and commercialization of a
novel ovarian cancer treatment.
We are democratizing clinical development through this innovative partnership- allowing individuals to be active participants in our ovarian program.
If our clinical trials are successful, RSO commits to provide the drug at cost to AZF for worldwide distribution to under-developed countries.
Support our work (link)
Join the RSO Family
Be an active part in our research. Even small gifts can make a
Here's an example of clinical trial costs:
Identifying patients that can participate based on biomarker
Costs of a patient to participate in
Support further academic research associated with new drug
~ $300,000 year
RSO Family Members receive -
Patient stories and progress
Zoom sessions with our team
For more information contact (link)
This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors.